Related Experiment Videos
[Clinical observations with clarithromycin in pediatrics].
T Sekiguchi1, T Okamoto, K Ohara
1Department of Pediatrics, Takamatsu Red Cross Hospital.
The Japanese Journal of Antibiotics
|February 1, 1989
Summary
Clarithromycin, an oral antibiotic, showed excellent results in treating 25 children with various bacterial infections. This study found TE-031 effective and safe for pediatric bacterial infections.
Area of Science:
- Pediatric infectious diseases
- Antibiotic research and development
- Pharmacology
Context:
- Acute bacterial infections in children pose significant health challenges.
- Effective and safe antibiotic options are crucial for pediatric care.
- Clarithromycin (TE-031) is an investigational antibiotic for bacterial infections.
Purpose:
- To evaluate the clinical efficacy and safety of clarithromycin (TE-031) in pediatric patients with acute bacterial infections.
- To assess bacterial eradication rates following clarithromycin treatment.
- To identify potential side effects associated with TE-031 administration in children.
Summary:
- Twenty-five children with acute bacterial infections (bronchitis, pneumonia, Mycoplasma pneumonia, pertussis, Campylobacter enteritis) received oral clarithromycin (TE-031).
- Clinical responses were good to excellent in 22 patients, with successful bacterial eradication observed in all 10 strains tested.
- No adverse side effects were reported during the study period.
Impact:
- Clarithromycin (TE-031) demonstrates significant potential as a safe and effective antibiotic for treating a range of bacterial infections in pediatric populations.
- The findings support the use of TE-031 in pediatric infectious disease management.
- Further research may confirm TE-031's role in the pediatric antibiotic armamentarium.